NCT06646679 Intelligent Segmentation Algorithm of Ultrasonic Image
| NCT ID | NCT06646679 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tongji Hospital |
| Condition | Segmentation |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2024-10-14 |
| Primary Completion | 2026-11-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2024-10-14 with a primary completion date of 2026-11-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project aims to enhance the performance of ultrasonic image analysis by optimizing and refining neural network algorithms, while also collecting and constructing extensive datasets relevant to ultrasonic imagery. The algorithm will be trained and evaluated in a data-driven manner, with test results facilitating accurate segmentation of regional block images and identification of characteristic ultrasonic anatomy. This approach will significantly advance the study and development of ultrasonic technology.
Eligibility Criteria
Inclusion Criteria: * None. Exclusion Criteria: * None.
Contact & Investigator
Mei Wei, M.D.
PRINCIPAL INVESTIGATOR
Tongji Hospital
Frequently Asked Questions
Who can join the NCT06646679 clinical trial?
This trial is open to participants of all sexes, studying Segmentation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06646679 currently recruiting?
Yes, NCT06646679 is actively recruiting participants. Contact the research team at liutzh@126.com for enrollment information.
Where is the NCT06646679 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT06646679 clinical trial?
NCT06646679 is sponsored by Tongji Hospital. The principal investigator is Mei Wei, M.D. at Tongji Hospital. The trial plans to enroll 5,000 participants.